Gold has been a strong asset for the year to date, supported by multiple tailwinds. Could Trump's budget bill send the gold ...

Investor interest in AI has surged as the technology continues to develop. Here are the ones to keep an eye on in FY26.

The leading broker has named these ASX 200 stocks as best buys this month. Here's why its analysts are bullish on ...

UBS currently has a buy rating and $9.30 price target on its shares. Another ASX dividend share that could be a buy is GQG ...

Consumer discretionary shares are impacted by interest rates. Here are two worth watching with upcoming RBA decisions in ...

The "Magnificent Seven" are giants of the stock market. Which of these two will be the winning investment in the long run?

Today we look at two top ASX dividend stocks I expect will deliver market beating passive income in FY 2026 and beyond.

Telstra has completed a multi-year turnaround, simplified its operations, and is now well-placed to deliver steady growth in ...

Whilst healthcare stocks are often described as underrepresented on the ASX, these two growth options could be buy low ...

SMI calculates an NPV of A$1.5 billion at a gold price of A$4,950/oz, IRR of 65% and payback period of 1.7 years. SMI expects ...

The combination of consistent earnings and reinvestment into growth can lead to the powerful force of compounding — where ...

As for income, the broker is expecting Sonic Healthcare to pay dividends per share of 107 cents in FY 2025 and then 109 cents ...